المؤلفون: Prokoph, Nina (University of Cambridge), Turner, Suzanne D. (University of Cambridge / Masaryk University), Burke, G. A. Amos (Cambridge University Hospitals NHS Foundation Trust), Montes-Mojarro, Ivonne A. (University of Tübingen), Matthews, Jamie D. (University of Cambridge), Trigg, Ricky M. (University of Cambridge), Brugières, Laurence (Institut Gustave Roussy), Riguad, Charlotte (Institut Gustave Roussy), Murray, Matthew J. (University of Cambridge / Cambridge University Hospitals NHS Foundation Trust), Johnston, Robert (Royal Belfast Hospital for Sick Children), Geoerger, Birgit (Université Paris-Saclay / Institut Gustave Roussy), Kenner, Lukas (University of Veterinary Medicine Vienna / Medical University of Vienna), Merkel, Olaf (Medical University of Vienna), Fend, Falko (University of Tübingen)

المصدر: British Journal of Haematology 202(5), 985-994 (2023)

مصطلحات موضوعية: Large-Cell Lymphoma, Lung-Cancer, Solid Tumors, Open-Label, Crizotinib, Mutations, Resistance, Alectinib, Children, Stat3

وصف الملف: application/pdf

Relation: isPartOf:https://phaidra.vetmeduni.ac.at/o:605[Open Access Publications]; https://phaidra.vetmeduni.ac.at/o:3428

الاتاحة: https://doi.org/10.1111/bjh.18953
https://phaidra.vetmeduni.ac.at/o:3428